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Medication is  the most common form of  intervention to prevent disease or slow disease 
progression, with guidelines for single diseases recommending  evidence based drug 
treatments. There remains the mismatch between prescribing guidelines for specific medical 
conditions and the range of clinical complexity found in individual adults with multiple 
morbidities. The resulting polypharmacy (use of multiple medicines) can be both appropriate 
and inappropriate and the key healthcare aim for individual patients is to ensure the on-going 
safe and effective use of their multiple medicines. 
NHS Scotland developed, designed  and implemented national policy to consider the patient 
pathway and the flow of work needed to be undertaken in clinical practice to address 
appropriate management of Polypharmacy.  Implementation across all 14 health boards serving 
a population of 5.5 million people in Scotland utilised Kotter’s 8 steps[1] for implementation 
of change supported by clinical and policy leadership, economic data and clinical outcome data. 
NHS Scotland have provided leadership for a European work plan. SIMPATHY , Stimulating 
Innovation in Managment of Polypharmacy and Adherence in the Elderly, (www.simpathy.eu) 
has benchmarked European strategies to address polypharmacy and through in-depth case 
studies in 10 EU countries, is developing strategies and tools to support innovation in 
polypharmacy and adherence management across Europe. 
Synthesis of the findings from application of change management tools such as Kotter, PESTEL 
(Political, Economic, Social,Technological, Environmental and Legal)  and SWOT ( Strenghts 
Weaknesses, Opportunities and Threats), together with the case studies serve to inform 
further innovation. Comparison was made to other EU countries, that had started to implement 
a programme.. 
Work undertaken in the Scottish programme has been used to develop an economic tool that 
may be used by other countries to explore the economic benefits of a national polypharmacy 
management programme. Transferability of innovation will be supported through publication 
of a reference book based on the findings of SIMPATHY. 
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Synthesis of findings confirmed that key principles of Kotter  influenced the successful  
implementation of national policy for management of polypharmacy in Scotland.  It was 
identified that policy and clinical  leadership  were essential drivers along  with a policy change 
that supported implementation in the service together with contractual arrangements . 
Lessons learned from national policy implementation in Scotland  and from local programmes 
in other EU countries, including facilitators and barriers, together with key features of an 
economic tool will inform innovation of integrated care at a policy level. 
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